Indications
Pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with HIV 1 without past or present evidence of resistance to the NNRTI class.
Composition
- Active substance
- doravirine
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Pifeltro
- Active substance
- doravirine
- ATC code
- J05AG06
- Therapeutic area
- HIV Infections
- Marketing authorisation holder
- Merck Sharp & Dohme B.V.
- Status
- Authorised